Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.

Oncotarget · 2017 · PMC5352126 · PMID 27861153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In Figure 1D , TgM9 showed a trend of fewer dysplastic lesions (2.2 ± 0.31) compared to their WT littermates (3 ± 1.09) in CAC, however the difference was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.